Pear Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pear Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2022.
  • Pear Therapeutics, Inc. Depreciation for the quarter ending December 31, 2022 was $928K, a 41.2% increase year-over-year.
  • Pear Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2022 was $3.35M, a 98.2% increase year-over-year.
  • Pear Therapeutics, Inc. annual Depreciation for 2022 was $3.35M, a 98.2% increase from 2021.
  • Pear Therapeutics, Inc. annual Depreciation for 2021 was $1.69M, a 343% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.35M +$1.66M +98.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $1.69M +$1.31M +343% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $381K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.